Stem Cell Therapy For Type 1 Diabetes Mellitus

Any potential stem cell based cure for t1dm should address the need for beta cell replacement as well as control of the autoimmune response to cells which express insulin.

Stem cell therapy for type 1 diabetes mellitus.

Cytotherapy 17 7 940 947. The primary function of stem cell therapy for diabetes is to repair and regenerate damaged tissue involving nerves blood vessels and even the kidneys and pancreas. Mesenchymal stem cell therapy for type 1 diabetes mellitus patients the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Likewise known as insulin dependent diabetes mellitus iddm for short and juvenile diabetes stem cell therapy to stop autoimmune attacks from destroying insulin producing pancreatic islet cells and insulin producing beta cells.

Type 1 diabetes mellitus t1dm is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells. The use of stem cells in regenerative medicine holds great promise for the cure of many diseases including type 1 diabetes mellitus t1dm. Insulin secreting adipose derived mesenchymal stromal cells with bone marrow derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Studies have shown improved glucose regulation and even improved kidney function following stem cell therapy for diabetes type 2 as well as type 1.

Listing a study does not mean it has been evaluated by the u s. As a result the body becomes insulin deficient and hyperglycemic.